Adaptive Biotechnologies Corporation Stock
Stocks
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
23:00:00 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 24.20 USD | -0.12% |
|
-0.33% | +49.01% |
| 08-20 | Adaptive Biotechnologies Insider Sold Shares Worth $3,135,850, According to a Recent SEC Filing | MT |
| 07-30 | Adaptive Biotechnologies Q2 Loss Widens, Revenue Rise | MT |
| Market Cap | 3.86B 3.33B 3.15B 2.86B 5.36B 369B 5.39B 37.42B 14.39B 188B 14.5B 14.19B 593B | P/E 2026 * |
-44.4x | P/E 2027 * | -137x |
|---|---|---|---|---|---|
| Enterprise Value | 3.8B 3.28B 3.1B 2.81B 5.28B 363B 5.3B 36.85B 14.17B 185B 14.28B 13.97B 584B | EV / Sales 2026 * |
13x | EV / Sales 2027 * | 10.5x |
| Free-Float |
97.94% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADPT | Delayed | |
CBOE
| ADPT | Real-time | |
|
Deutsche Boerse AG
| 1HM | Delayed | |
|
Boerse Muenchen
| 1HM | Real-time | |
|
Börse Stuttgart
| 1HM | Delayed | |
|
Tradegate
| 1HM | Real-time |
Last Transcript : Adaptive Biotechnologies Corporation
| 1 day | -0.12% | ||
| 1 week | -0.33% | ||
| Current month | -2.89% | ||
| 1 month | -4.69% | ||
| 3 months | +29.20% | ||
| 6 months | +70.18% | ||
| Current year | +49.01% |
| 1 week | 23.53 |  | 24.79 |
| 1 month | 23.53 | | 26.87 |
| Current year | 12 | | 26.87 |
| 1 year | 12 | | 26.87 |
| 3 years | 2.28 | | 26.87 |
| 5 years | 2.28 | | 39.79 |
| 10 years | 2.28 | | 71.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chad Robins
CEO | Chief Executive Officer | 51 | 08/09/2009 |
Kyle Piskel
DFI | Director of Finance/CFO | 42 | 08/04/2024 |
Julie Rubinstein
PSD | President | 54 | 01/02/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Chad Robins
CHM | Chairman | 51 | - |
Robert Hershberg
BRD | Director/Board Member | 63 | 01/02/2013 |
Peter Neupert
BRD | Director/Board Member | 70 | 01/12/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/31/26 A | Don | Director | -12,539 | 0.0079% | ||
| 8/26/26 A | Sell | Director | -9,615 | 0.0060% | ||
| 8/18/26 A | Exercice | Director | 60,664 | 0.0379% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | -0.33% | +79.39% | +288.44% | 3.86B | |
| +5.65% | -2.16% | +255.37% | +42.62% | 3.9B | |
| -2.76% | -3.90% | +28.28% | +61.61% | 3.29B | |
| +0.48% | -1.22% | +271.47% | +503.36% | 2.6B | |
| -1.24% | -2.69% | -30.86% | -32.66% | 2.05B | |
| -6.10% | -9.32% | +40.19% | - | 1.54B | |
| +0.16% | -1.10% | +23.73% | +38.38% | 1.07B | |
| -2.97% | -10.79% | +134.05% | -37.33% | 971M | |
| -1.13% | +0.73% | -0.52% | +49.53% | 616M | |
| -2.60% | -4.29% | -35.96% | -15.94% | 505M | |
| Average | -1.06% | -4.35% | +76.51% | +99.78% | 2.04B | |
| Weighted average by Cap. | -0.15% | -3.25% | +109.59% | +145.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 293M 253M 239M 217M 407M 28.01B 409M 2.84B 1.09B 14.25B 1.1B 1.08B 45.04B | 359M 309M 293M 265M 497M 34.25B 500M 3.47B 1.34B 17.43B 1.35B 1.32B 55.07B |
| Net income | -85.78M -73.91M -69.98M -63.43M -119M -8.19B -120M -831M -320M -4.17B -322M -315M -13.17B | -27.55M -23.74M -22.48M -20.37M -38.22M -2.63B -38.42M -267M -103M -1.34B -103M -101M -4.23B |
| Net Debt | -58.99M -50.83M -48.13M -43.62M -81.84M -5.64B -82.25M -572M -220M -2.87B -222M -217M -9.06B | -104M -89.46M -84.71M -76.78M -144M -9.92B -145M -1.01B -387M -5.05B -390M -381M -15.95B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | $24.20 | -0.12% | 1,238,268 |
| 10/09/26 | $24.23 | -0.78% | 1,071,432 |
| 09/09/26 | $24.42 | +0.33% | 1,106,844 |
| 08/09/26 | $24.34 | +0.25% | 1,358,580 |
| 04/09/26 | $24.28 | -1.18% | 1,404,316 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADPT Stock
Select your edition
All financial news and data tailored to specific country editions
